Downloaded from Monitoring and Evaluation of HIV/AIDS WPP: Situation, challenges and next steps A contribution to the Blueprint for Business Action on HIV/AIDS Erick Maville, GBC Europe Downloaded from

Downloaded from What is Monitoring, What is Evaluation? Current companies’ practices in M&E GBC/GTZ Workshop on M&E, Frankfurt, Sept. 20, 2005 Next steps Main challenges Why is M&E important?

Downloaded from What is Monitoring ? What is Evaluation ? Evaluation: episodic assessment of overall achievements and the extent to which they can be attributed to specific interventions. Involves measuring the outcomes and impact of a program over time in order to investigate its effectiveness. Monitoring: routine, regular assessment of ongoing activities and progress. Involves counting the input and routinely looking at the process and the output (quality of services delivery).

Downloaded from National AIDS Councils: monitoring and evaluation operations manual, UNAIDS, World Bank, 2002 What is Monitoring ? What is Evaluation ?

Downloaded from Why is M&E important? M&E: a crucial component to integrate at the beginning of any program 1)Providing early evidence of program effectiveness 2) Ensuring that interventions are effective or need to be orientated 3) Communicating with those who are involved: employees and stakeholders (donors, partners, customers, etc.)

Downloaded from 1.Providing a user friendly methodology for WPP implementation in a diversity of environments and locations 2.Presenting for each component of a WPP a brief description of implementation status (traffic light presentation) 3.Measuring inputs and key ouputs But : 1.It is not an evaluation tool 2.No providing outcomes and impact indicators Key findings of the Frankfurt workshop The roadmap used by multinational companies (UNILEVER, LAFARGE, CFAO…) as a monitoring tool

Downloaded from Main challenges 1) Establishing a “comprehensive M&E system” for WPP (still not systematic) 2) Harmonizing M&E methods between companies 3) Developing outcomes and Impact indicators 4) Providing benchmark data to compare corporate performances on HIV/Aids 5) Encouraging reporting practices on HIV/AIDS by companies

Downloaded from Upcoming > By March 2006, development of a “user friendly” CD- ROM on M&E (joint project GBC/GTZ) 1) Simplified guidelines to define a M&E workplan 2) Library of existing tools (Roadmap, Checklist assessment, KAP Survey, prevalence survey, etc) 3) Key indicators by component of a WPP 4) Benchmark data (sector-based and country based)

Downloaded from "This Blueprint provides modules for businesses of all sizes with Clear, Crisp and Concise action points on HIV/AIDS programming!" Mr Emmanuel ALHASSAN: Special Advisor, Public-Private Partnerships, National Action Committee on AIDS, Nigeria " I am delighted to be part of the Editorial Board of this guide, which in my opinion will help the private sector in its fight against HIV/AIDS. I think that it will be a "plus" in the practical process of finding solutions to effectively fight against this scourge. It will help harmonize the HIV programs of different size companies of the private sector " Dr Prince-Igor ANY-GRAH: Occupational Health & Private Physician, Côte d'Ivoire " This blueprint offers a practical guide on how to set up workplace programs, giving useful hints on the building blocks that would ensure successful response to HIV/AIDS for businesses " Mr George WAINAINA: Program Manager Kenya HIV/AIDS Business Council, Kenya " I think the Blueprint for Business Action will assist the companies in Malawi to adopt some of the strategies with ease" Ms Rose KUMWENDA NG'OMA: Program Director, Malawi Business Coalition Against AIDS, Malawi. " A simple tool, prompting for action " Dr. Henriette MEILO: Dermatologist, DARVIR Douala, Cameroon Dr Christophe Longuet: Medical Manager Africa HIV/AIDS, MSD. Blueprint Coordinator Dr Donald de Korte: Director, HIV Access Programs, MSD. Chair of Editorial Board Thank you! Now we listen to you...